Find the  BEST  Cannabis

States are responding cautiously to federal marijuana rescheduling, which may have unintended legal consequences for medical cannabis in South Carolina.

The federal government's decision to reclassify medical marijuana as a Schedule III drug has met with mixed reactions from Nebraska officials, with some leaders maintaining their opposition while others support the move for research purposes. Despite the federal change and a successful 2024 voter initiative legalizing medical cannabis in the state, implementation remains slow as state officials continue to review regulations and potential legal challenges.

The industrial hemp industry faces a critical definition problem as unregulated intoxicating products undermine the growth of legitimate fiber and grain markets. To realize hemp's multi-billion dollar potential, advocates propose a clear statutory distinction between industrial and cannabinoid uses, alongside a comprehensive regulatory framework for food, feed, and manufacturing.

Florida is in a legal dispute with cannabis operator Trulieve over alleged environmental violations, including unpermitted surfaces and erosion, at a cultivation site.

Marc Rodriguez, CEO of Green Leaf Business Solutions, has joined the board of the U.S. Cannabis Roundtable as his company becomes a member organization. This partnership emphasizes the increasing importance of workforce compliance and operational discipline within the cannabis industry amidst evolving federal regulations.

Virginia lawmakers rejected Governor Abigail Spanberger's proposed amendments to a retail cannabis market bill, leaving her with 30 days to either sign the original legislation or veto it. The impasse centers on disagreements over the regulatory framework, licensing limits, and social equity provisions, prolonging the state's legal uncertainty regarding cannabis sales.

MJBizDaily provides defensible cannabis pricing data to support legal professionals in validating claims and reducing uncertainty during litigation. This independent market data helps anchor legal cases in realistic pricing realities.

Abstrax and Western Washington University released a white paper revealing that biological sex significantly influences the behavioral effects of the terpenes linalool and b-myrcene, especially when combined with CBD. The research provides peer-reviewed evidence for the entourage effect and suggests that cannabis brands should consider sex-specific data when formulating and positioning products.

An investigation into potential securities fraud was launched following a significant drop in a cannabis company's stock price on December 15.